Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09
Vaccination rates among the nation's adolescents showed significant increases in 2008 compared with the previous year, but coverage still is less than 50 percent for three vaccines specifically recommended for preteens, according to recent survey findings from the CDC. Since 2006, the CDC has conducted a national survey to estimate vaccination coverage among adolescents ages 13–17. The survey includes queries about two single–dose vaccines that were licensed in 2005 – tetravalent meningococcal conjugate vaccine, or MCV4, and tetanus, diphtheria, acellular pertussis vaccine, or Tdap – and one vaccine licensed for use as a three–dose series in girls, teens and young women in 2006 – quadrivalent human papillomavirus, or HPV, vaccine. MCV4 is marketed by Sanofi Pasteur as Menactra; the quadrivalent HPV vaccine is sold as Gardasil by Merck & Co. Inc. All three products are recommended to be given at age 11 or 12.
Vaccination coverage for MCV4 increased from 32.4 percent in 2007 to 41.8 percent in 2008, and Tdap coverage increased from 30.4 percent to 40.8 percent during the same period. The number of girls who had received one or more doses of HPV vaccine increased from 25.1 percent to 37.2 percent. However, fewer then 20 percent of girls had received all three of the recommended doses.
In addition to the three aforementioned vaccines, the ACIP also recommends that adolescents receive the following vaccinations if they did not receive them during childhood:
- two doses of measles, mumps, rubella, or MMR, vaccine;
- three doses of hepatitis B vaccine; and
- two doses of varicella vaccine.
Related Articles
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09
Relevance Score: 68%
Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
BMC Infectious Diseases, 10/06/09
Relevance Score: 68%
One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09
Relevance Score: 68%
Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China
Hepatology, 10/20/09
Relevance Score: 67%
Human Papillomavirus Vaccine: The Current Picture
The Female Patient, 10/07/09
Relevance Score: 67%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
New England Journal of Medicine, 12/04/09
A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination
International Journal of Infectious Diseases, 12/04/09
Slowing Progression Along the Allergic Disease Continuum: Quo Vadit Immunotherapy
Pediatric Asthma, Allergy & Immunology, 12/04/09
Article Search
Sponsor


See Latest Articles


